decitabine
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are not candidates for standard induction chemotherapy.
Form: powder for concentrate for infusion solution
Active substance Dosage decitabine 50 mg ATC: L01BC08
Manufacturer: Eugia Pharma Specialities Limited
-
The drug is intended for the treatment of adult patients with newly diagnosed or secondary acute myeloid leukemia (AML) who are not candidates for standard induction chemotherapy.
Form: powder for solution for infusion
Active substance Dosage decitabine 50 mg ATC: L01BC08
Manufacturer: San Pharmaceutical Industries Ltd.
-
The drug is indicated for the treatment of adult patients with newly diagnosed or secondary acute myeloid leukemia (AML) who, according to the WHO classification, are not candidates for standard induction chemotherapy.
Form: lyophilisate for solution for injection
Active substance Dosage decitabine 50 mg ATC: L01BC08
Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))